サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540797

プロテオミクス市場レポート：分析タイプ、コンポーネントタイプ、技術、用途、エンドユーザー、地域別、2024～2032年

Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End-User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
プロテオミクス市場レポート：分析タイプ、コンポーネントタイプ、技術、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロテオミクス市場規模は2023年に363億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに1,262億米ドルに達し、2024～2032年の間に14.4%の成長率（CAGR）を示すと予測しています。

プロテオミクスとは、プロテオーム、その構造、生理機能を大規模に研究することです。1994年、Mark Wilkinsは、ゲノムから翻訳されるタンパク質をプロテオームと呼び、生物体内で合成されるタンパク質全体を初めて定義しました。プロテオームには、既存のタンパク質が様々な条件にさらされたときに起こる修飾や変化が含まれます。プロテオミクスは、診断マーカーの検出、細胞内の病原体の理解、さまざまな疾患におけるタンパク質経路の解釈とともに、タンパク質の定量化と同定のためにさまざまな技術を応用します。プロテオミクスはまた、タンパク質の生産速度や相互作用パターンを評価し、創薬や個別化医薬品の開発に幅広く応用できます。

創薬とバイオテクノロジーの研究開発の増加とともに、個別化治療への嗜好が高まっていることが、市場の成長を促進する主要要因です。プロテオミクスシステムは、医薬品の化学合成と生物学的試験に必要な時間、コスト、資源を削減し、創薬プロセスを簡素化します。さらに、バイオマーカー同定や質量分析ベースのプロテオミクスに関連する機会が、市場の成長をさらに後押ししています。さらに、タンパク質技術の包括的分析における技術的浸透の増加が市場を牽引しています。これらの技術には、エレクトロスプレーイオン化-液体クロマトグラフィー-質量分析（ESI-LC-MS）、表面プラズマ共鳴、マイクロアレイ、タンパク質分画システム、X線結晶構造解析などが含まれます。これらの進歩により、タンパク質の徹底的な定量・定性分析が可能になり、がん治療法や治療法の同定が可能になります。広範な研究開発（R&D）に対する政府の有利な政策など、その他の要因も市場の成長を後押ししています。

本レポートで扱う主要質問

  • プロテオミクス市場の世界市場規模は？
  • 2024～2032年にかけての世界のプロテオミクス市場の予想成長率は？
  • 世界のプロテオミクス市場を牽引する主要因は何か？
  • 世界のプロテオミクス市場に対するCOVID-19の影響は？
  • 世界のプロテオミクス市場の技術別内訳は？
  • 世界のプロテオミクス市場のエンドユーザー別内訳は？
  • プロテオミクス市場の世界における主要地域は？
  • 世界のプロテオミクス市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のプロテオミクス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：分析タイプ別

  • 構造プロテオミクス
  • 機能プロテオミクス
  • タンパク質発現プロテオミクス

第7章 市場内訳：コンポーネントタイプ別

  • コアプロテオミクスサービス
  • バイオインフォマティクスソフトウェアと関連サービス

第8章 市場内訳：技術別

  • 分光法
  • クロマトグラフィー
  • 電気泳動
  • タンパク質マイクロアレイ
  • X線結晶構造解析
  • 表面プラズモン共鳴
  • その他

第9章 市場内訳：用途別

  • タンパク質発現プロファイリング
  • プロテオーム鉱業
  • 翻訳後修飾

第10章 市場内訳：エンドユーザー別

  • 臨床診断ラボ
  • 研究機関（創薬）
  • その他

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Bruker Corporation
    • Creative Proteomics
    • Danaher Corporation
    • GE Healthcare Inc.
    • Horiba Ltd.
    • Luminex Corporation
    • Merck Group
    • Perkinelmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Proteomics Market: Major Drivers and Challenges
  • Figure 2: Global: Proteomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2023
  • Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2023
  • Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Proteomics (Research Organizations-Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Proteomics (Research Organizations-Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: United States: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Canada: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: China: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: China: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Japan: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: India: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: India: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: South Korea: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Australia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Indonesia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Europe: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Germany: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: France: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: France: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Italy: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Spain: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Russia: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Latin America: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Brazil: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Mexico: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Others: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: Proteomics Industry: SWOT Analysis
  • Figure 95: Global: Proteomics Industry: Value Chain Analysis
  • Figure 96: Global: Proteomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Proteomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million US$), 2024-2032
  • Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million US$), 2024-2032
  • Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Proteomics Market Structure
  • Table 9: Global: Proteomics Market: Key Players
目次
Product Code: SR112024A2156

The global proteomics market size reached US$ 36.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.2 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032.

Proteomics refers to the study of proteomes, their structure and physiological functions on a large-scale. In 1994, Mark Wilkins first coined the term proteome for the proteins that are translated from genome, to denote the whole set of proteins synthesized within a living organism. It encompasses the modifications and alterations that take place in the existing protein when it is exposed to varying conditions. Proteomics applies various technologies for the quantification and identification of proteins, along with the detection of diagnostic markers, understanding of pathogens in cells and interpretation of protein pathways in different diseases. It also evaluates the rate of protein production and the interaction patterns of proteins due to which it finds extensive applicability in drug discovery and the development of personalized medications.

The growing preference for personalized drugs, along with increasing research and development in drug discovery and biotechnology, is the key factor driving the growth of the market. Proteomic systems reduce the time, cost and resources needed for the chemical synthesis and biological testing of drugs and simplify the process of drug discovery. Furthermore, opportunities related to biomarker identification and mass spectrometry-based proteomics are favoring the market growth further. Additionally, the market is driven by increasing technological penetration in the comprehensive analysis of protein techniques. These techniques include Electrospray Ionization-Liquid Chromatography-Mass Spectrometry (ESI-LC-MS), surface plasma resonance, microarray, protein fractionation systems and X-ray crystallography. These advancements enable a thorough quantitative and qualitative analysis of proteins and identification of cancer therapies and treatments. Other factors, such as favorable government policies for extensive research and development (R&D) are also augmenting the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global proteomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on analysis type, component type, technology, application and end-user.

Breakup by Analysis Type:

Structural Proteomics

Functional Proteomics

Protein Expression Proteomics

Breakup by Component Type:

Core Proteomics Services

Bioinformatics Software and Related Services

Breakup by Technology:

Spectroscopy

Chromatography

Electrophoresis

Protein Microarrays

X-Ray Crystallography

Surface Plasmon Resonance

Others

Breakup by Application:

Protein Expression Profiling

Proteome Mining

Post-translational Modifications

Breakup by End-User:

Clinical Diagnostic Laboratories

Research Organizations (Drug Discovery)

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report

  • 1. How big is the global proteomics market?
  • 2. What is the expected growth rate of the global proteomics market during 2024-2032?
  • 3. What are the key factors driving the global proteomics market?
  • 4. What has been the impact of COVID-19 on the global proteomics market?
  • 5. What is the breakup of the global proteomics market based on the technology?
  • 6. What is the breakup of the global proteomics market based on the end-user?
  • 7. What are the key regions in the global proteomics market?
  • 8. Who are the key players/companies in the global proteomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Proteomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Analysis Type

  • 6.1 Structural Proteomics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Functional Proteomics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Protein Expression Proteomics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Component Type

  • 7.1 Core Proteomics Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics Software and Related Services
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Spectroscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Chromatography
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Electrophoresis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein Microarrays
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 X-Ray Crystallography
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Surface Plasmon Resonance
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Protein Expression Profiling
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Proteome Mining
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Post-translational Modifications
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Clinical Diagnostic Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research Organizations (Drug Discovery)
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bruker Corporation
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Creative Proteomics
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 GE Healthcare Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Horiba Ltd.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Luminex Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck Group
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Perkinelmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Promega Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Waters Corporation
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis